home / openregs / documents

documents: FDA-2025-P-3849-0004

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2025-P-3849-0004 FDA FDA-2025-P-3849 Determination That OZEMPIC (Semaglutide) Solution, 2 Milligrams Per 1.5 Milliliters Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness Notice Determinations 2026-04-30T04:00:00Z 2026 4     2026-04-30T18:12:42Z 2026-08435 0 0 09000064b92b5df8

Links from other tables

  • 1 row from regs_document_id in fr_regs_crossref
Powered by Datasette · Queries took 0.443ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API